PERSPECTA

News from every angle

← Back to headlines

Lupin Signs Agreement with Tenpoint Therapeutics for YUVEZZI Commercialization

Lupin has entered into an exclusive agreement with Tenpoint Therapeutics to commercialize YUVEZZI in Europe and the UK, expanding its market reach.

20 Aug, 06:41 — 20 Aug, 06:41
PostShare

Sources

Showing 1 of 1 sources
moneycontrol13d ago

Lupin signs exclusive agreement with Tenpoint Therapeutics to commercialise YUVEZZI in Europe, UK,... - Moneycontrol.com

Lupin signs exclusive agreement with Tenpoint Therapeutics to commercialise YUVEZZI in Europe, UK,...  Moneycontrol.com

Read full article →

Related Stories

US-Iran Conflict Escalates as Tehran Retaliates Against American Bases

17m ago

BP Names Ian Tyler Chairman After Boardroom Upheaval

22m ago

Everus Construction and California Resources Finalize Major Corporate Acquisitions

41m ago

Nvidia Nears $14 Billion Acquisition of AI Startup Hugging Face

1h ago